
Product Information
A nutritionally complete, fibre free, ready-to-use enteral tube feed.
Link copied!
Indications
For use in the dietary management of:
- Disease-related malnutrition.
- Patients requiring a residue-restricted diet.
Important Notice
- Not for parenteral use.
- Not suitable for patients with galactosaemia.
- Not suitable for patients with cow’s milk protein allergy.
- Not suitable for infants under 1 year of age.
- Use with caution in children aged 1-6 years of age.
- Use with caution in individuals with a seafood allergy.
Direction for Use
- Shake well before use.
- Use at room temperature.
- Handle aseptically to ensure product remains sterile.
- Usage to be determined by a healthcare professional.
Storage
- Store in a cool, dry place.
- Once opened, store in the refrigerator.
- Discard unused content after 24 hours.
Order Information
Contact Nutricia Customer Care 1800 889 480
Nutrison | Product Code | Units per carton |
500ml Bottle | 78796 | 12 |
1000ml OpTri Bottle | 132202 | 8 |
Ingredients
Full ingredients list and nutritional information available on Factsheet.
Allergen & Cultural Information
- Contains: cow’s milk protein, soy, fish oil.
- Does not contain: wheat, egg, nuts*, lupins.
- Halal certified (500ml bottle only).
- No Halal forbidden ingredients.
- No Kosher forbidden ingredients.
- No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
- Low lactose (lactose <2g/100g).
References
- World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. 2007; WHO technical report series ; no. 935.
- Kuyumcu S, Menne D, Curcic J, et al. Noncoagulating enteral formula can empty faster from the stomach: A double-blind, randomized crossover trial using magnetic resonance imaging. Journal of Parenteral and Enteral Nutrition. 2015;39:544-551.
- van den Braak CC, Klebach M, Abrahamse E, et al. A novel protein mixture containing vegetable proteins renders enteral nutrition products noncoagulating after in vitro gastric digestion. Clinical Nutrition. 2013;32:765- 771.
- Klebach M, Hofman Z, Bluemel S, et al. Effect of protein type in enteral nutrition formulas on coagulation in the stomach in vivo: Post hoc analyses of a randomized controlled trial with MRI. Abstract presented at Clinical Nutrition Week, January 16–19; Austin, Tx. Journal of Parenteral and Enteral Nutrition. 2016;40:134(21).
- Luttikhold J, van Norren K, Rijna H, et al. Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. Am J Clin Nutr. 2016;103:435–43.
- Abrahamse E, van der Lee S, van den Braak S, et al. Gastric non coagulation of enteral tube feed yields faster gastric emptying of protein in a dynamic in vitro model. Abstract presented at 34th ESPEN Congress. Sept 8-11; Barcelona, Spain. Clinical Nutrition Supplements. 2012;7:PP239(119).
- Liu J, Klebach M, Abrahamse E, et al. Specific protein mixture reduces coagulation: An in vitro stomach model study mimicking a gastric condition in critically ill patients. Poster presented at 38th ESPEN Congress. 17-20 September; Copenhagen, Denmark. Clinical Nutrition. 2016;35:MON-P182 (S220).
Additional Information
^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5
* Peanut (Arachis hypogaea), Almond (Amygdalus communis L .), Hazelnut Corylus avellana), Walnut (Juglans regia), Cashew (Anacardium occidentale), Pecan nut (Carya illinoiesis (Wangenh.) K. Koch), Brazil nut (Bertholletia excelsa), Pistachio nut (Pistacia vera), Macadamia nut and Queensland nut (Macadamia ternifolia), and products thereof.